Atlas Trials

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Clinical trial NCT02640820 · UNKNOWN

Trial details

NCT number
NCT02640820
Sponsor
RXi Pharmaceuticals, Corp.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Common WartsHPV (Human Papillomavirus)Periungual WartsPlantar Warts
Start date
2015-12-01
Primary completion
2018-01-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.